Epidemiological profiles between equol producers and nonproducers: A genomewide association study of the equol-producing phenotype

Genes and Nutrition

Volumn 7, Issue 4, 2012, Pages 567-574

  Hong, Kyung Won ^a   Ko, Kwang Pil ^a,b   Ahn, Younjhin ^a   Kim, Cheong Sik ^a   Park, Seon Joo ^a   Park, Jae Kyung ^a   Kim, Sung Soo ^a   Kim, Yeonjung ^a  

^a Korea Centers for Disease Control and Prevention   (South Korea)

^b Gachon University   (South Korea)

Author keywords

Equol; HACE1; Isoflavone; Korean

Indexed keywords

EQUOL;

ADULT; ALLELE; ANTHROPOMETRY; ARTICLE; ASIAN; BIOSYNTHESIS; BLOOD CHEMISTRY; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HACE1 GENE; HEREDITY; HUMAN; HUMAN GENOME; KOREAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MEASUREMENT; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

EID: 84872191509     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1007/s12263-012-0292-8     Document Type: Article

References (39)

1. Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, Tsukamoto T, Mori M (2002) Is daidzein non-metabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration. Jpn J Clin Oncol 32:296-300 (Pubitemid 43102798)
2. Akaza H, Miyanaga N, Takashima N, Nagata Y, Hirao Y, Tsukamoto T, Fujioka T, Mori M, Kim WJ, Song JM, Pantuck AJ (2004) Comparisons of percent equol producers between prostate cancer patients and controls: Case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol 34:86-89 (Pubitemid 43115325)
3. Alekel DL, Van Loan MD, Koehler KJ, Hanson LN, Stewart JW, Hanson KB, Kurzer MS, Peterson CT (2010) The soy isoflavones for reducing bone loss (SIRBL) study: A 3-y randomized controlled trial in postmenopausal women. Am J Clin Nutr 91:218-230
4. Andres S, Abraham K, Appel KE, Lampen A (2011) Risks and benefits of dietary isoflavones for cancer. Crit Rev Toxicol 41:463-506
5. Anglesio MS, Evdokimova V, Melnyk N, Zhang L, Fernandez CV, Grundy PE, Leach S, Marra MA, Brooks-Wilson AR, Penninger J, Sorensen PHB (2004) Differential expression of a novel arkyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney. Hum Mol Genet 13:2061-2074 (Pubitemid 39377829)
6. Atkinson C, Berman S, Humbert O, Lampe JW (2004a) In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production. J Nutr 134:596-599 (Pubitemid 38298502)
7. Atkinson C, Berman S, Humbert O, Lampe JW (2004b) The in vitro metabolism of daidzein by human intestinal bacteria. J Nutr 134:596-599
8. Atkinson C, Frankenfeld CL, Lampe JW (2005) Gut bacterial metabolism of the soy isoflavone daidzein: Exploring the relevance to human health. Exp Biol Med 230:155-170 (Pubitemid 40293689)
9. Brink E, Coxam V, Robins S, Wahala K, Cassidy A, Branca F (2008) Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: A randomized, doubleblind, placebo controlled study. Am J Clin Nutr 87:761-770 (Pubitemid 351364559)
10. Bruce CK, Howard P, Nowak NJ, Hoban PR (2003) Molecular analysis of region t(5;6)(q21;q21) in Wilms tumor. Cancer Genet Cytogenet 141:106-113 (Pubitemid 36269209)
11. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton RK, Fertuck KC, Hall GE, Wang Q, Berkiranov S, Sementchenko V, Fox EA, Silver PA, Gingeras TR, Liu XS, Brown M (2006) Genomewide analysis of estrogen receptor binding sites. Nat Genet 38:1289-1297 (Pubitemid 44646291)
12. Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, Ban HJ, Yoon D, Lee MH, Kim DJ, Park M, Cha SH, Kim JW, Han BG, Min H, Ahn Y, Park MS, Han HR, Jang HY, Cho EY, Lee JE, Cho NH, Shin C, Park T, Park JW, Lee JK, Cardon L, Clarke G, McCarthy MI, Lee JY, Lee JK, Oh B, Kim HL (2009) A large-scale genomewide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet 41:527-534
13. Clarkson TB (2002) Soy, soy phytoestrogens and cardiovascular disease. J Nutr 132:566S-569S (Pubitemid 34208771)
14. Dai Q, Franke AA, Jin F, Shu XO, Hebert JR, Custer LJ, Cheng J, Gao YT, Zheng W (2002) Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev 11:815-821 (Pubitemid 35014883)
15. DellaPenna D (1999) Nutritional genomics: Manipulating plant micronutrients to improve human health. Science 285:375-379 (Pubitemid 29343953)
16. Grace PB, Taylor JI, Botting NP, Fryatt T, Oldfield MF, Al-Maharik N, Bingham SA (2003) Quantification of isoflavones and lignans in serum using isotope dilution liquid chromatography tandem mass spectrometry. Rapid Commun Mass Spectrom 17:1350-1357 (Pubitemid 36750020)
17. Heinonen S, Wahala K, Adlercreutz H (1999) Identification of isoflavone metabolites dihydrodaidzein, dihydrogenistein, 6-OHO-dma, and cis-4-OH-equol in human urine by gas chromatography-mass spectroscopy using authentic reference compounds. Anal Biochem 274:211-219 (Pubitemid 29489491)
18. Huang Y, de Reynies A, de Leval L, Ghazi B, Martin-Garcia N, Travert M, Bosq J, Briere J, Thomas E, Coppo P, Marafioti T, Emile JF, Delfau-Larue MH, Schmitt C, Gaulard P (2010) Gene expression profiling identifies emerging oncogenic pathway operating in extranodal NK/T-cell lymphoma, nasal type. Blood 115:1226-1236
19. Hwang SJ, Yang Q, Meigs JB, Pearce EN, Fox CS (2007) A genomewide association for kidney function and endocrinerelated traits in the NHLBI's Framingham heart study. BMC Med Genet 8:S10
20. Jakacka M, Ito M, Weiss J, Chien PY, Gehm BD, Jameson JL (2001) Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J Biol Chem 276:13615-13621
21. Ko KP, Min H, Ahn Y, Park SJ, Kim CS, Park JK, Kim SS (2011) A prospective study investigating the association between environmental tobacco smoke exposure and the incidence of type 2 diabetes in never smokers. Ann Epidemiol 21:42-47
22. Kwon DY, Daily JW III, Kim HJ, Park S (2010) Antidiabetic effects of fermented soybean products on type 2 diabetes. Nutr Res 30:1-13
23. Levy D, Ehret GB, Rice K et al (2009) Genomewide association study of blood pressure and hypertension. Nat Genet 41:677-687
24. Ma DF, Qin LQ, Wang PY, Katoh R (2008) Soy isoflavone intake increases bone mineral density in the spine of menopausal women: Meta-analysis of randomized controlled trials. Clin Nutr 27:57-64
25. Messina M, Gardner C, Barnes S (2002) Gaining insight into the health effects of soy but a long way still to go: Commentary on the fourth international symposium on the role of soy in preventing and treating chronic disease. J Nutr 132:547S-551S (Pubitemid 34208768)
26. O'Hara AM, Shanahan F (2006) The gut flora as a forgotten organ. EMBO Rep 7:688-693 (Pubitemid 43986264)
27. Ozasa K, Nakao M, Watanabe Y, Hayashi K, Miki T, Mikami K, Mori M, Sakauchi F, Washio M, Ito Y, Suzuki K, Wakai K, Group AT (2004) Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men. Cancer Sci 95:65-71 (Pubitemid 38208409)
28. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: A tool set for whole-genome association and populationbased linkage analyses. Am J Hum Genet 81:559-575 (Pubitemid 47330214)
29. Rabbee N, Speed TP (2006) A genotype calling algorithm for affymetrix SNP arrays. Bioinformatics 22:7-12 (Pubitemid 43057002)
30. Rowland I, Berman S, Humber O, Lampe JW (1999) Metabolism of oestrogen and phytoestrogens: Role of the gut microflora. Biochem Soc Trans 27:304-308 (Pubitemid 29086054)
31. Sakar FH, Li YW (2002) Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metast Rev 21:265-280
32. Setchell KDR (1998) Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68:1333S-1346S (Pubitemid 28550909)
33. Setchell KDR, Clerici C (2010) Equol: Parmacokinetics and biological actions. J Nutr 140:1363S-1368S
34. Setchell KDR, Brown NM, Lydeking-Olsen E (2002) The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132:3577-3584 (Pubitemid 35435031)
35. Song KB, Atkinson C, Frankenfeld CL, Jokela T, Wahala K, Tomas WK, Lampe JW (2006) Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J Nutr 136:1347-1351
36. Tormala RM, Appt S, Clarkson TB, Tikkanen MJ, Ylikorkala O, Mikkola TS (2007) Individual differences in equol production capability modulate blood pressure in tibolone-treated postmenopausal women: Lack of effect of soy supplementation. Climacteric 10:471-479 (Pubitemid 350211298)
37. Wang HC, Klein JR (2001) Immune function of thyroid stimulating hormone and receptor. Crit Rev Immunol 21:327-337
38. Yuan JP, Wang JH, Liu X (2007) Metabolism of dietary soy isoflavones to equol by human intestinal microflora-implications for health. Mol Nutr Food Res 51:765-781 (Pubitemid 47173687)
39. Zhang L, Anglesio M, O'Sullivan M, Zhang F, Yang G, Sarao R, Nghiem MP, Farrar J, Arceci RJ, Sorensen PH, Penninger JM (2007) The E3 ligase HACE1 is a critical chromosomal 6q21 tumor suppressor involved in multiple cancers. Nat Med 13:1060-1069 (Pubitemid 47517503)